AGBL1
Basic information
Region (hg38): 15:86079871-87049169
Links
Phenotypes
GenCC
Source:
- Fuchs' endothelial dystrophy (Supportive), mode of inheritance: AD
- corneal dystrophy, Fuchs endothelial, 8 (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Corneal dystrophy, Fuchs endothelial, 8 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 24094747 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AGBL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 108 | 11 | 122 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 110 | 12 | 5 |
Variants in AGBL1
This is a list of pathogenic ClinVar variants found in the AGBL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-86142052-G-C | AGBL1-related disorder | Benign (Jun 18, 2019) | ||
15-86143689-T-C | AGBL1-related disorder | Likely benign (May 14, 2019) | ||
15-86143774-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
15-86143782-G-C | not specified | Uncertain significance (May 29, 2024) | ||
15-86143816-T-C | not specified | Uncertain significance (Dec 21, 2022) | ||
15-86143818-C-T | Likely benign (Apr 01, 2024) | |||
15-86154442-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
15-86154558-A-G | not specified | Uncertain significance (Jul 10, 2024) | ||
15-86158938-A-C | not specified | Uncertain significance (Dec 22, 2023) | ||
15-86158947-A-G | not specified | Uncertain significance (Sep 09, 2024) | ||
15-86158987-T-C | not specified | Uncertain significance (Nov 19, 2022) | ||
15-86159011-G-A | not specified | Likely benign (Aug 27, 2024) | ||
15-86224904-C-T | AGBL1-related disorder | Benign (Mar 15, 2019) | ||
15-86224921-A-G | not specified | Uncertain significance (Dec 14, 2023) | ||
15-86247678-C-G | not specified | Uncertain significance (Dec 11, 2023) | ||
15-86247682-C-T | not specified | Uncertain significance (Mar 20, 2023) | ||
15-86247740-A-G | not specified | Uncertain significance (Jan 07, 2022) | ||
15-86247766-G-A | Benign (Jan 01, 2024) | |||
15-86247817-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
15-86247832-G-C | not specified | Uncertain significance (Jan 03, 2022) | ||
15-86247883-G-A | Likely benign (Aug 01, 2023) | |||
15-86256857-G-T | not specified | Uncertain significance (Jul 27, 2024) | ||
15-86256872-G-A | not specified | Uncertain significance (Oct 24, 2024) | ||
15-86256902-A-C | Corneal dystrophy, Fuchs endothelial, 8 | Uncertain significance (Mar 01, 2023) | ||
15-86256923-C-T | AGBL1-related disorder | Benign (Jul 15, 2019) |
GnomAD
Source:
dbNSFP
Source:
- Function
- FUNCTION: Metallocarboxypeptidase that mediates deglutamylation of target proteins. Catalyzes the deglutamylation of polyglutamate side chains generated by post-translational polyglutamylation in proteins such as tubulins. Also removes gene-encoded polyglutamates from the carboxy-terminus of target proteins such as MYLK. Acts as a long-chain deglutamylase and specifically shortens long polyglutamate chains, while it is not able to remove the branching point glutamate, a process catalyzed by AGBL5/CCP5. {ECO:0000250|UniProtKB:Q09M05}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Carboxyterminal post-translational modifications of tubulin
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.0919
- hipred
- N
- hipred_score
- 0.219
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0741
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Agbl1
- Phenotype
Gene ontology
- Biological process
- proteolysis;C-terminal protein deglutamylation;protein side chain deglutamylation
- Cellular component
- cytosol
- Molecular function
- metallocarboxypeptidase activity;zinc ion binding;tubulin binding